Alexion Pharmaceuticals
ALXN
#620
Rank
NZ$73.13 B
Marketcap
NZ$330.89
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Alexion Pharmaceuticals (ALXN)

Earnings in 2021 (TTM): NZ$0.74 Billion

According to Alexion Pharmaceuticals's latest financial reports the company's current earnings are NZ$6.26 Billion. In 2020 the company made an earning of NZ$1.22 Billion a decrease over its 2019 earnings that were of NZ$4.09 Billion.

Earnings history for Alexion Pharmaceuticals from 2001 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)NZ$0.74 B-38.77%
2020NZ$1.22 B-70.15%
2019NZ$4.09 B562.93%
2018NZ$0.61 B-47.32%
2017NZ$1.17 B-3.98%
2016NZ$1.22 B23.29%
2015NZ$0.98 B-37.62%
2014NZ$1.58 B64.99%
2013NZ$0.96 B30.97%
2012NZ$0.73 B75.72%
2011NZ$0.41 B53.93%
2010NZ$0.27 B78.4%
2009NZ$0.15 B125.97%
2008NZ$67.33 M-137.23%
2007-NZ$0.19 Billion-27.23%
2006-NZ$0.25 Billion10.16%
2005-NZ$0.23 Billion69.7%
2004-NZ$0.14 Billion-9.64%
2003-NZ$0.15 Billion10.27%
2002-NZ$0.14 Billion96.74%
2001-NZ$67.83 Million